HIPAA Compliance Must Take Center Stage in Mergers and Acquisitions

Firms involved in mergers and acquisitions involving covered entities (CE) and business associates (BAs) run the risk of acquiring HIPAA liabilities along with another company’s assets. In order to manage that risk, they need to know exactly what they’re buying, even if that means asking time-consuming and difficult questions as part of transaction due diligence.

That’s the word from attorneys involved in mergers and acquisitions, who say that the purchaser needs to incorporate HIPAA-related due diligence early in the process. BAs in particular may warrant extra scrutiny in mergers and acquisitions, depending on how they’re set up and on how much of their business involves protected health information (PHI).

“Problems are ubiquitous,” says Kate Hardey, an attorney with McGuireWoods LLP in Virginia. “Companies are certainly trying. But in a higher percentage of deals we look at, there is some type of HIPAA concern that we want to correct.”

According to Hardey, the most common concerns found in health care mergers and acquisitions include whether the merger or acquisition target has conducted security risk assessments, and whether the target has proper HIPAA policies and procedures.

HIPAA issues figure into “so many different types of deals,” Hardey tells RPP. “It’s not just health systems purchasing physician practices.” For example, issues frequently arise when a BA buys or merges with another BA, and when a CE buys a BA, she says.

This document is only available to subscribers. Please log in or purchase access.


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field